TransMedics Group Inc - TMDX Profit before deduction of interest, taxes, depreciation and amortization
The rapid expansion of organ preservation systems and strong cash inflows are driving an upward trend, as confirmed by TransMedics Group (TMDX) EBITDA dynamics. The value of 127.34 determines the magnitude of the operating profit metric. Success is based on global surgeon confidence in device quality, the protection of technologies by unique patents, and the strict reliance of clinics on a proven supplier due to the critical nature of transplantation risks.
Summary analytical data breakdowns for TransMedics Group Inc (TMDX)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio TransMedics Group|TMDX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio TransMedics Corp|TMDX - Company Aggregate Debts|Debts to Book Value TransMedics|TMDX - Company Long-Term Debts|Company Short-Term Indebtedness TransMedics|Interim Coverage Ratio transmedics.com
- earnings and market multiples details:
TMDX - Net Profit|Future Profit TransMedics Group|TMDX - P/E Multiple|Forward P/E Multiple transmedics.com|TMDX - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TransMedics|TMDX - Operating profit before deduction of amortization|Earnings per share for the trailing year TransMedics|TMDX - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months transmedics.com|TMDX - Earnings per share growth in current year|Net earnings per one share growth forecast for next year TransMedics Group
Summary company analytics:TransMedics Group
This indicator captures net cash flow from operating activities before depreciation and taxes, allowing for an assessment of operational efficiency and the business's stage of maturity. By analyzing the distribution of EBITDA across periods, an investor can see how TransMedics Group (TMDX) strategy to monopolize the organ perfusion market converts technological superiority into real profit, confirming the asset's fundamental stability and capitalization.
Who TransMedics Group competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|ATEC (atecspine.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Artivion AORT|ENOV - Operating profit before deduction of amortization|Integra - Operating profit EBITDA|Profit before interest, taxes and amortization Establishment Labs Inc|BBNX: Operating profit EBITDA|Operating profit before amortization IRMD|EMBC (Embecta) - Operating profit EBITDA|Tandem Diabetes Care Inc (TNDM) - Operating income before deduction of amortization|Operating profit EBITDA AXGN|Operating profit before deduction of amortization SI-BONE Medical SIBN|Operating profit EBITDA OFIX (Orthofix Medical Inc.)|Operating profit EBITDA bioventus.com BVS|KIDS - Profit before payment of interest, taxes and amortization|TMCI: Profit before payment of interest, taxes and amortization|SRTA (Strata Critical Medical Corp) - Operating profit before deduction of amortization|Carlsmed Medical - Income before deduction of interest, taxes and amortization|RXST (RxSight, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization ClearPoint CLPT|Profit before payment of interest, taxes and amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Operating profit before depreciation charges|Sight Sciences, Inc - Operating profit before deduction of amortization|Operating profit EBITDA orchestrabiomed.com OBIO|Anika - Operating profit EBITDA|Operating income before deduction of amortization inspiremd.com NSPR|zhjmedical.com (ZJYL) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VANI (Vivani Medical)|Profit before payment of interest, taxes and amortization Xtant Medical Holdings, Inc.|Operating profit before deduction of amortization NeuroOne Medical Technologies Corp. (NMTC)|Operating profit EBITDA MODD|MYO - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Envoy Medical COCH|VVOS: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies - Company profit before taxes, interest and amortization|TNON (Tenon Medical, Inc.) - Operating profit before deduction of amortization|LFWD: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Autonomix Medical Inc.|IVF: Income before deduction of interest, taxes and amortization|Operating profit EBITDA BBLG|Operating profit EBITDA Axonics, Inc (AXNX)|Profit before payment of interest, taxes and amortization BIOLASE, Inc. BIOL|DYNT: Operating profit before amortization|FNA - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization INVO Bioscience, Inc. INVO
